Transbronchial biopsy without fluoroscopy in patients with diffuse roentgenographic infiltrates and the acquired immunodeficiency syndrome

Abstract

Transbronchial biopsy with the flexible fiberoptic bronchoscope is usually performed with the assistance of fluoroscopy in order to increase diagnostic yield and decrease the incidence of pneumothorax. We have compared the results of transbronchial biopsy performed with or without fluoroscopic guidance in patients with diffuse roentgenographic infiltrates who had or were suspected of having the acquired immunodeficiency syndrome. Neither the sensitivity for Pneumocystis carinii (88.5 versus 92%) nor the percentage of patients developing pneumothoraces after transbronchial biopsy (8.6 versus 11.1%) was significantly different in those patients who had the procedure without fluoroscopic guidance compared with those in whom fluoroscopy was used. There were no patients with significant hemorrhage or deaths in either group. This complication rate compares favorably with other reports of transbronchial biopsy in immunocompromised patients in which fluoroscopy was used. "Blind" transbronchial biopsy is a safe and effective diagnostic procedure in this patient population.